Dow Up2.00% Nasdaq Up1.66%

Sunesis Pharmaceuticals, Inc. (SNSS)

-NasdaqCM
0.69 Up 0.00(0.57%) 4:00PM EST
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2014Dec 31, 2013Dec 31, 2012
Total Revenue 5,734   7,956   3,754  
Cost of Revenue -   -   -  
Gross Profit 5,734   7,956   3,754  
Operating Expenses
Research Development27,665  28,891  29,185  
Selling General and Administrative23,112  10,838  9,175  
Non Recurring -   -   -  
Others -   -   -  
Total Operating Expenses -   -   -  
Operating Income or Loss (45,043) (31,773) (34,606)
Income from Continuing Operations
Total Other Income/Expenses Net3,760  92  (7,490)
Earnings Before Interest And Taxes(41,283)(31,681)(42,096)
Interest Expense1,719  2,917  1,855  
Income Before Tax(43,002)(34,598)(43,951)
Income Tax Expense -   -   -  
Minority Interest -   -   -  
Net Income From Continuing Ops(43,002)(34,598)(43,951)
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income (43,002) (34,598) (43,951)
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares (43,002) (34,598) (43,951)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.